Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/296160 stock hub

XKON/296160 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/296160is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

73.3B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/296160

In the news

Latest news · XKON/296160

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-62

P25 n/aP50 n/aP75 n/a

ROIC-17.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/296160 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

137

Groups with data

Currency

KRW

Showing 137 of 137 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 73.3B
Price	KRW 4,770
Price currency	KRW
Sic	2836
Symbol	xkon/296160
Website	https://www.progen.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.8%
FCF yield	-17.76%
P/B ratio	3.94x
P/S ratio	162.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	97.46%
Gross Profit	KRW 438.6M
Net Income	KRW -15.3B
Pretax Margin	-3,389.08%
ROA	-8.14
Roa5y	-5.84
ROCE	-19.36
ROE	-61.97
Roe5y	-13.41
ROIC	-17.31
Roic5y	-19.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-24.42%
Revenue Growth	1,700x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.01
Assets	KRW 52.9B
Cash	KRW 3.2B
Current Assets	KRW 3.8B
Current Liabilities	KRW 14.6B
Debt	KRW 30.1B
Debt Equity	KRW 1.62
Debt FCF	KRW -2.31
Equity	KRW 18.6B
Interest Coverage	-6.38
Liabilities	KRW 34.3B
Long Term Assets	KRW 49.1B
Long Term Liabilities	KRW 19.7B
Net Cash	KRW -26.9B
Net Cash By Market Cap	KRW -36.63
Net Debt Equity	KRW 1.44
Tangible Book Value	KRW 17.6B
Tangible Book Value Per Share	KRW 3,806
WACC	-0.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.26
Net Working Capital	KRW -3.2B
Quick ratio	0.23
Working Capital	KRW -10.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-420.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-24.41%
200-day SMA	6,729.5
50-day SMA	5,864.7
50-day SMA vs 200-day SMA	50under200
All Time High	9,970
All Time High Change	-52.16%
All Time High Date	2025-07-14
All Time Low	2,465
All Time Low Change	93.51%
All Time Low Date	2023-11-20
ATR	364.9
Beta	-1.1
Beta1y	-0.46
Beta2y	-0.26
Ch YTD	-36.74
High	4,920
High52	9,970
High52 Date	2025-07-14
High52ch	-52.16%
Low	4,600
Low52	4,040
Low52 Date	2026-05-06
Low52ch	18.07%
Ma50ch	-18.67%
Price vs 200-day SMA	-29.12%
RSI	23.37
RSI Monthly	38.05
RSI Weekly	31.56
Sharpe ratio	-0.33x
Sortino ratio	-0.36
Total Return	-420.84%
Tr YTD	-36.74
Tr1m	-19.83%
Tr1w	0.42%
Tr3m	-19.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -7.4B
Operating margin	-1,647.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,552,417%
Net Borrowing	10,102,931,140
Shares Insiders	33.54%
Shares Institutions	0.32%
Shares Out	15,375,079

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -13B
Average Volume	13,416.75x
Bv Per Share	3,806.8
CAPEX	KRW -7.9B
Ch1m	-19.83
Ch1w	0.42
Ch1y	-24.41
Ch3m	-19.15
Ch6m	-19.02
Change	-1.24%
Change From Open	-2.65
Close	4,830
Days Gap	1.45
Depreciation Amortization	1,057,555,900
Dollar Volume	89,747,550
EBIT	KRW -7.4B
EBITDA	KRW -6.4B
EPS	KRW -3,307
F Score	3
FCF	KRW -13B
FCF Per Share	KRW -847
Financing CF	12,601,431,130
Fiscal Year End	December
Founded	1,998
Investing CF	-7,543,416,090
Is Primary Listing	1
Ma150	6,420
Ma150ch	-25.7%
Ma20	5,281.8
Ma20ch	-9.69%
Net CF	-96,946,170
Open	4,900
Position In Range	53.13
Ppne	39,917,837,730
Price Date	2026-05-08
Ptbv Ratio	4.18
Relative Volume	1.4x
Revenue	450,000,000x
Tr6m	-19.02%
Volume	18,815
Z Score	-0.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/296160 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/296160 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/296160?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+33.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/296160 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

23.4

Below 30: short-term oversold

Price vs 200-day MA

-29.1%

50/200-day relationship not available

Beta (5Y)

-1.10

Less volatile than the market

Sharpe ratio

-0.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/296160

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/296160 stock rating?

xkon/296160 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/296160 analysis?

The full report lives at /stocks/xkon/296160/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/296160?

The latest report frames xkon/296160 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/296160 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.